| 05/15/2026 7:30 AM | Replimune Group (1737953) Subject RTW INVESTMENTS, LP (1493215) Filed by | Form SCHEDULE 13G/A | |
| 05/12/2026 5:32 PM | Replimune Group (1737953) Subject SUVRETTA CAPITAL MANAGEMENT, LLC (1569064) Filed by | Form SCHEDULE 13G | |
| 05/07/2026 10:04 AM | PRICE T ROWE ASSOCIATES INC /MD/ (80255) Filed by Replimune Group (1737953) Subject | Form SCHEDULE 13G/A | |
| 04/07/2026 8:07 PM | Replimune Group (1737953) Issuer Weinand Dieter (1744419) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/07/2026 8:08 PM | Hill Emily Luisa (1778279) Reporting Replimune Group (1737953) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/07/2026 8:08 PM | Peeples-Dyer Veleka (1978705) Reporting Replimune Group (1737953) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/07/2026 8:08 PM | Replimune Group (1737953) Issuer SLATTERY JOSEPH P (1246530) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/07/2026 8:08 PM | Pucci Paolo (1436861) Reporting Replimune Group (1737953) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/07/2026 8:09 PM | Dhingra Kapil (1456849) Reporting Replimune Group (1737953) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/07/2026 8:09 PM | Patel Sushil (1860609) Reporting Replimune Group (1737953) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/07/2026 8:09 PM | Replimune Group (1737953) Issuer Schwendenman Andrew (1977879) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for REPL and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Replimune Group and its competitors with MarketBeat's FREE daily newsletter.
|
| 04/07/2026 8:09 PM | Balachandran Madhavan (1555508) Reporting Replimune Group (1737953) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/07/2026 8:10 PM | Replimune Group (1737953) Issuer Xynos Konstantinos (1956241) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/07/2026 8:10 PM | Oliger Christy J. (1822092) Reporting Replimune Group (1737953) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/07/2026 8:10 PM | Astley-Sparke Philip (1376491) Reporting Replimune Group (1737953) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/07/2026 8:11 PM | Replimune Group (1737953) Issuer Sarchi Christopher (1986597) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/07/2026 8:15 PM | 667, L.P. (1551139) Reporting Baker Bros. Advisors (0) GP BAKER BROS. ADVISORS LP (1263508) Reporting Baker Brothers Life Sciences LP (1363364) Reporting BAKER FELIX (1087940) Reporting BAKER JULIAN (1087939) Reporting Replimune Group (1737953) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/06/2026 3:30 PM | Replimune Group (1737953) Issuer Sarchi Christopher (1986597) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/20/2026 3:15 PM | Astley-Sparke Philip (1376491) Reporting Replimune Group (1737953) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/17/2026 7:28 AM | Forbion Capital Fund III Cooperatief U.A. (1747586) Filed by Replimune Group (1737953) Subject | Form SCHEDULE 13G/A | |
| 02/03/2026 7:05 AM | Replimune Group (1737953) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/03/2026 7:12 AM | Replimune Group (1737953) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 01/12/2026 7:00 AM | Replimune Group (1737953) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/19/2025 4:10 PM | Replimune Group (1737953) Issuer Schwendenman Andrew (1977879) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/19/2025 4:11 PM | Replimune Group (1737953) Issuer Sarchi Christopher (1986597) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/19/2025 4:12 PM | Hill Emily Luisa (1778279) Reporting Replimune Group (1737953) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/19/2025 4:13 PM | Replimune Group (1737953) Issuer Xynos Konstantinos (1956241) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/19/2025 4:14 PM | Patel Sushil (1860609) Reporting Replimune Group (1737953) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/11/2025 3:30 PM | Dhingra Kapil (1456849) Reporting Replimune Group (1737953) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/09/2025 3:00 PM | Dhingra Kapil (1456849) Reporting Replimune Group (1737953) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/04/2025 3:30 PM | Patel Sushil (1860609) Reporting Replimune Group (1737953) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/02/2025 3:11 PM | Patel Sushil (1860609) Reporting Replimune Group (1737953) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/19/2025 3:30 PM | Replimune Group (1737953) Issuer Xynos Konstantinos (1956241) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/19/2025 3:31 PM | Replimune Group (1737953) Issuer Sarchi Christopher (1986597) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/14/2025 11:19 AM | PRICE T ROWE ASSOCIATES INC /MD/ (80255) Filed by Replimune Group (1737953) Subject | Form SCHEDULE 13G/A | |
| 11/14/2025 7:31 AM | Replimune Group (1737953) Subject RTW INVESTMENTS, LP (1493215) Filed by | Form SCHEDULE 13G | |
| 11/06/2025 3:20 PM | Replimune Group (1737953) Filer | Form S-3/A | |
| 11/06/2025 7:20 AM | Replimune Group (1737953) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/06/2025 7:07 AM | Replimune Group (1737953) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 10/20/2025 6:20 AM | Replimune Group (1737953) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/18/2025 8:20 AM | Replimune Group (1737953) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
Read this warning immediately (Ad) Porter Stansberry, founder of one of the world's largest financial research firms, says he's breaking the biggest story of his 26-year career. A famous historian whose books have sold over 45 million copies in 65 languages is warning of a structural shift so large it has only one historical parallel - 1776.
One Stanford economist calls it 'the biggest change ever - bigger than electricity, bigger than the steam engine.' Stansberry outlines the stocks to buy, the stocks to sell, and three money moves to position yourself on the right side of this shift. Read Porter Stansberry's full breakdown and protect your wealth now |
| 09/04/2025 3:05 PM | Replimune Group (1737953) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/19/2025 7:30 PM | Hill Emily Luisa (1778279) Reporting Replimune Group (1737953) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/07/2025 7:05 AM | Replimune Group (1737953) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/07/2025 7:07 AM | Replimune Group (1737953) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 07/25/2025 3:20 PM | Replimune Group (1737953) Filer | Form ARS | |
| 07/22/2025 7:18 AM | Replimune Group (1737953) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/24/2025 3:30 PM | Replimune Group (1737953) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/22/2025 8:23 PM | Replimune Group (1737953) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 05/22/2025 8:30 PM | Replimune Group (1737953) Filer | Form S-3 Registration statement under Securities Act of 1933 | |
| 05/22/2025 8:34 PM | Replimune Group (1737953) Filer | Form S-3 Registration statement under Securities Act of 1933 | |
| 05/22/2025 8:44 PM | Hill Emily Luisa (1778279) Reporting Replimune Group (1737953) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/22/2025 8:44 PM | Patel Sushil (1860609) Reporting Replimune Group (1737953) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/22/2025 8:45 PM | Replimune Group (1737953) Issuer Schwendenman Andrew (1977879) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/22/2025 8:46 PM | Replimune Group (1737953) Issuer Xynos Konstantinos (1956241) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/22/2025 8:47 PM | Astley-Sparke Philip (1376491) Reporting Replimune Group (1737953) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/22/2025 8:42 PM | Replimune Group (1737953) Issuer Sarchi Christopher (1986597) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/22/2025 4:12 PM | Replimune Group (1737953) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 05/22/2025 7:05 AM | Replimune Group (1737953) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |